Symptomatic therapy and rehabilitation in primary progressive multiple sclerosis

Area of Science:

• Neurology
• Immunology
• Rehabilitation Medicine

Background:

• Multiple sclerosis (MS) is a central nervous system autoimmune disease causing chronic neurological disability.
• Primary progressive MS (PPMS), affecting 10% of cases, features steady functional decline without acute attacks and has a worse prognosis than other MS types.
• PPMS significantly impacts quality of life, yet research often favors relapsing-remitting MS due to available treatments.

Purpose of the Study:

• To outline symptomatic treatment and rehabilitation strategies for individuals with MS, with a specific focus on PPMS.
• To emphasize the importance of a multidisciplinary approach in optimizing outcomes for PPMS patients.
• To address the restoration of functional independence, societal reintegration, and quality of life in PPMS management.

Main Methods:

• Review of current literature on symptomatic treatment and rehabilitation for MS.
• Focus on strategies tailored for the progressive nature of PPMS.
• Integration of a neuropalliative approach for advanced disease stages.

Main Results:

• A multidisciplinary approach is essential for optimizing medical, psychological, and social outcomes in PPMS.
• Rehabilitation efforts should concentrate on disability management, enhancing participation, and maintaining functional independence.
• A neuropalliative approach is recommended as the disease progresses to manage symptoms and improve quality of life.

Conclusions:

• Effective management of PPMS requires a comprehensive, multidisciplinary strategy.
• Rehabilitation plays a vital role in mitigating disability and promoting societal reintegration for PPMS patients.
• A neuropalliative approach is integral to enhancing the quality of life for individuals with progressive multiple sclerosis.